The chickenpox vaccine is a lens that can protect almost anyone who receives the vaccine from catching chickenpox. It is also called the varicella vaccine because chickenpox is caused by the varicella-zoster virus. The vaccine is made from live, but weakened, or weakened, virus.
We aims to provide a complete knowledgeable report so that the readers will benefit from it. The report is properly examined and compiled by industry experts and will shed light on the key information that requires from the clients.
Case numbers are resurging in parts of the world where the COVID-19 pandemic was waning, falling in places that saw huge surges recently, and just beginning to rise in previously little-impacted parts of the globe.
Studying and analyzing the impact of Coronavirus COVID-19 on the Varicella Virus (Chickenpox) Vaccine industry, the report provide in-depth analysis and professtional advices on how to face the post COIVD-19 period.
Market Segment by Product Type
Monovalent Vaccine
Combination Vaccine
Market Segment by Product Application
Children
Teenagers
Adults
Finally, the report provides detailed profile and data information analysis of leading company.
GSK
Merck & Co.
Sanofi Pasteur
Green Cross
Shanghai Institute
BCHT
Changsheng
Keygen
Biken
Insights and Tools:
Projected and forecast revenue values are in constant U.S. dollars, unadjusted for inflation.
Product values and regional markets are estimated by market analyst, data analyst and people from related industry, based on companys' revenue and applications market respectively.
The data sources include but not limited to reports of companys,international organizations and governments, MMI market surveys,and related industry news.
Analyses of global market trends, with historical data, estimates for 2022 and projections of compound annual growth rates (CAGRs) through 2027
The market research includes historical and forecast data from like demand, application details, price trends, and company shares by geography, especially focuses on the key regions like United States, European Union, China, and other regions.
In addition, the report provides insight into main drivers,challenges,opportunities and risk of the market and strategies of suppliers. Key players are profiled as well with their market shares in the global market discussed.
Research Objectives
1.To study and analyze the global Varicella Virus (Chickenpox) Vaccine consumption (value) by key regions/countries, product type and application, history data from 2017 to 2021, and forecast to 2027.
2.To understand the structure of Varicella Virus (Chickenpox) Vaccine market by identifying its various subsegments.
3.Focuses on the key global Varicella Virus (Chickenpox) Vaccine manufacturers, to define, describe and analyze the value, market share, market competition landscape, Porter's five forces analysis, SWOT analysis and development plans in next few years.
4.To analyze the Varicella Virus (Chickenpox) Vaccine with respect to individual growth trends, future prospects, and their contribution to the total market.
5.To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
6.To project the consumption of Varicella Virus (Chickenpox) Vaccine submarkets, with respect to key regions (along with their respective key countries).
7.To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
8.To strategically profile the key players and comprehensively analyze their growth strategies.
Table of Contents
Global Varicella Virus (Chickenpox) Vaccine Market Research Report 2022, Forecast to 2027
1 Market Study Overview
1.1 Study Objectives
1.2 Varicella Virus (Chickenpox) Vaccine Introduce
1.3 Combined with the Analysis of Macroeconomic Indicators
1.4 Brief Description of Research methods
1.5 Market Breakdown and Data Triangulation
2 Global Trend Summary
2.1 Varicella Virus (Chickenpox) Vaccine Segment by Type
2.1.1 Monovalent Vaccine
2.1.2 Combination Vaccine
2.2 Market Analysis by Application
2.2.1 Children
2.2.2 Teenagers
2.2.3 Adults
2.3 Global Varicella Virus (Chickenpox) Vaccine Market Comparison by Regions (2017-2027)
2.3.1 Global Varicella Virus (Chickenpox) Vaccine Market Size (2017-2027)
2.3.2 North America Varicella Virus (Chickenpox) Vaccine Status and Prospect (2017-2027)
2.3.3 Europe Varicella Virus (Chickenpox) Vaccine Status and Prospect (2017-2027)
2.3.4 China Varicella Virus (Chickenpox) Vaccine Status and Prospect (2017-2027)
2.3.5 Japan Varicella Virus (Chickenpox) Vaccine Status and Prospect (2017-2027)
2.3.6 Southeast Asia Varicella Virus (Chickenpox) Vaccine Status and Prospect (2017-2027)
2.4 Basic Product Information
2.4.1 Basic Product Information & Technology Development History
2.4.2 Product Manufacturing Process
2.4.3 Interview with Major Market Participants
2.4.4 High-end Market Analysis and Forecast
2.5 Coronavirus Disease 2019 (Covid-19): Varicella Virus (Chickenpox) Vaccine Industry Impact
2.5.1 Varicella Virus (Chickenpox) Vaccine Business Impact Assessment - Covid-19
2.5.2 Market Trends and Varicella Virus (Chickenpox) Vaccine Potential Opportunities in the COVID-19 Landscape
2.5.3 Measures / Proposal against Covid-19
3 Competition by Manufacturer
3.1 Global Varicella Virus (Chickenpox) Vaccine Sales and Market Share by Manufacturer (2017-2022)
3.2 Global Varicella Virus (Chickenpox) Vaccine Revenue and Market Share by Manufacturer (2017-2022)
3.3 Global Varicella Virus (Chickenpox) Vaccine Industry Concentration Ratio (CR5 and HHI)
3.4 Top 5 Varicella Virus (Chickenpox) Vaccine Manufacturer Market Share
3.5 Top 10 Varicella Virus (Chickenpox) Vaccine Manufacturer Market Share
3.6 Date of Key Manufacturers Enter into Varicella Virus (Chickenpox) Vaccine Market
3.7 Key Manufacturers Varicella Virus (Chickenpox) Vaccine Key Manufacturers
3.8 Mergers & Acquisitions Planning
4 Analysis of Varicella Virus (Chickenpox) Vaccine Industry Key Manufacturers
4.1 GSK
4.1.1 Compan Detail
4.1.2 GSK Varicella Virus (Chickenpox) Vaccine Product Introduction, Application and Specification
4.1.3 GSK 131 Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.1.4 Main Business Overview
4.1.5 GSK News
4.2 Merck & Co.
4.2.1 Compan Detail
4.2.2 Merck & Co. Varicella Virus (Chickenpox) Vaccine Product Introduction, Application and Specification
4.2.3 Merck & Co. Varicella Virus (Chickenpox) Vaccine Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.2.4 Main Business Overview
4.2.5 GSK News
4.3 Sanofi Pasteur
4.3.1 Compan Detail
4.3.2 Sanofi Pasteur Varicella Virus (Chickenpox) Vaccine Product Introduction, Application and Specification
4.3.3 Sanofi Pasteur Varicella Virus (Chickenpox) Vaccine Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.3.4 Main Business Overview
4.3.5 Sanofi Pasteur News
4.4 Green Cross
4.4.1 Compan Detail
4.4.2 Green Cross Varicella Virus (Chickenpox) Vaccine Product Introduction, Application and Specification
4.4.3 Green Cross Varicella Virus (Chickenpox) Vaccine Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.4.4 Main Business Overview
4.4.5 Green Cross News
4.5 Shanghai Institute
4.5.1 Compan Detail
4.5.2 Green Cross Varicella Virus (Chickenpox) Vaccine Product Introduction, Application and Specification
4.5.3 Shanghai Institute Varicella Virus (Chickenpox) Vaccine Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.5.4 Main Business Overview
4.5.5 Shanghai Institute News
4.6 BCHT
4.6.1 Compan Detail
4.6.2 BCHT Varicella Virus (Chickenpox) Vaccine Product Introduction, Application and Specification
4.6.3 BCHT Varicella Virus (Chickenpox) Vaccine Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.6.4 Main Business Overview
4.6.5 BCHT News
4.7 Changsheng
4.7.1 Compan Detail
4.7.2 Changsheng Varicella Virus (Chickenpox) Vaccine Product Introduction, Application and Specification
4.7.3 Changsheng Varicella Virus (Chickenpox) Vaccine Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.7.4 Main Business Overview
4.7.4 Main Business Overview
4.8 Keygen
4.8.1 Compan Detail
4.8.2 Keygen Varicella Virus (Chickenpox) Vaccine Product Introduction, Application and Specification
4.8.3 Keygen Varicella Virus (Chickenpox) Vaccine Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.8.4 Main Business Overview
4.8.5 Keygen News
4.9 Biken
4.9.1 Compan Detail
4.9.2 Biken Varicella Virus (Chickenpox) Vaccine Product Introduction, Application and Specification
4.9.3 Biken Varicella Virus (Chickenpox) Vaccine Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.9.4 Main Business Overview
4.9.5 Biken News
5 Global Varicella Virus (Chickenpox) Vaccine Market Segment by Big Type
5.1 Global Varicella Virus (Chickenpox) Vaccine Revenue, Sales and Market Share by Big Type (2017-2022)
5.1.1 Global Varicella Virus (Chickenpox) Vaccine Sales and Market Share by Big Type (2017-2022)
5.1.2 Global Varicella Virus (Chickenpox) Vaccine Revenue and Market Share by Big Type (2017-2022)
5.2 Monovalent Vaccine Sales Growth Rate and Price
5.2.1 Global Monovalent Vaccine Sales Growth Rate (2017-2022)
5.2.2 Global Monovalent Vaccine Price (2017-2022)
5.3 Combination Vaccine Sales Growth Rate and Price
5.3.1 Global Combination Vaccine Sales Growth Rate (2017-2022)
5.3.2 Global Combination Vaccine Price (2017-2022)
6 Global Varicella Virus (Chickenpox) Vaccine Market Segment by Big Application
6.1 Global Varicella Virus (Chickenpox) Vaccine Sales Market Share by Big Application (2017-2022)
6.2 Children Sales Growth Rate (2017-2022)
6.3 Teenagers Sales Growth Rate (2017-2022)
6.4 Adults Sales Growth Rate (2017-2022)
7 Global Varicella Virus (Chickenpox) Vaccine Forecast
7.1 Global Varicella Virus (Chickenpox) Vaccine Revenue, Sales and Growth Rate (2022-2027)
7.2 Varicella Virus (Chickenpox) Vaccine Market Forecast by Regions (2022-2027)
7.2.1 North America Varicella Virus (Chickenpox) Vaccine Market Forecast (2022-2027)
7.2.2 Europe Varicella Virus (Chickenpox) Vaccine Market Forecast (2022-2027)
7.2.3 China Varicella Virus (Chickenpox) Vaccine Market Forecast (2022-2027)
7.2.4 Japan Varicella Virus (Chickenpox) Vaccine Market Forecast (2022-2027)
7.2.5 Southeast Asia Varicella Virus (Chickenpox) Vaccine Market Forecast (2022-2027)
7.2.6 Other Regions Varicella Virus (Chickenpox) Vaccine Market Forecast (2022-2027)
7.3 Varicella Virus (Chickenpox) Vaccine Market Forecast by Type (2022-2027)
7.3.1 Global Varicella Virus (Chickenpox) Vaccine Sales Forecast by Type (2022-2027)
7.3.2 Global Varicella Virus (Chickenpox) Vaccine Market Share Forecast by Type (2022-2027)
7.4 Varicella Virus (Chickenpox) Vaccine Market Forecast by Application (2022-2027)
7.4.1 Global Varicella Virus (Chickenpox) Vaccine Sales Forecast by Application (2022-2027)
7.4.2 Global Varicella Virus (Chickenpox) Vaccine Market Share Forecast by Application (2022-2027)
8 Market Analysis
8.1.1 Market Overview
8.1.2 Market Opportunities
8.1.3 Market Risk
8.1.4 Market Driving Force
8.1.5 Porter's Five Forces Analysis
8.1.6 SWOT Analysis
9 Varicella Virus (Chickenpox) Vaccine Related Market Analysis
9.1 Upstream Analysis
9.1.1 Macro Analysis of Upstream Markets
9.1.2 Key Players in Upstream Markets
9.1.3 Upstream Market Trend Analysis
9.1.4 Varicella Virus (Chickenpox) Vaccine Manufacturing Cost Analysis
9.2 Downstream Market Analysis
9.2.1 Macro Analysis of Down Markets
9.2.2 Key Players in Down Markets
9.2.3 Downstream Market Trend Analysis
9.2.4 Sales Channel, Distributors, Traders and Dealers
10 Research Findings and Conclusion
List of Tables and Figures
Figure Product Picture Varicella Virus (Chickenpox) Vaccine
Figure Market Concentration Ratio and Market Maturity Analysis of Varicella Virus (Chickenpox) Vaccine
Figure Bottom-up and Top-down Approaches for This Report
Figure Part of Our External Database
Figure Part of Our External Database
Figure Key Executives Interviewed
Table Global Varicella Virus (Chickenpox) Vaccine Market Size by Big Type
Figure Global Market Share of Varicella Virus (Chickenpox) Vaccine by Big Type in 2021
Figure Monovalent Vaccine Picture (2017-2022)
Global Varicella Virus (Chickenpox) Vaccine Market Size by Big Application
Table Global Varicella Virus (Chickenpox) Vaccine Market Size by Application
Figure Global Varicella Virus (Chickenpox) Vaccine Market Share by Big Application in 2021
Figure Children Picture
Figure Teenagers Picture
Figure Adults Picture
Table Global Varicella Virus (Chickenpox) Vaccine Comparison by Regions (M USD) (2017-2027)
Figure Global Varicella Virus (Chickenpox) Vaccine Market Size (Million US$) (2017-2027)
Figure North America Varicella Virus (Chickenpox) Vaccine Revenue (Million US$) Growth Rate (2017-2027)
Figure Europe Varicella Virus (Chickenpox) Vaccine Revenue (Million US$) Growth Rate (2017-2027)
Figure China Varicella Virus (Chickenpox) Vaccine Revenue (Million US$) Growth Rate (2017-2027)
Figure Japan Varicella Virus (Chickenpox) Vaccine Revenue (Million US$) Growth Rate (2017-2027)
Figure Southeast Asia Varicella Virus (Chickenpox) Vaccine Revenue (Million US$) Growth Rate (2017-2027)
Table Business Impact Assessment - Covid-19
Table Market Trends and Varicella Virus (Chickenpox) Vaccine Potential Opportunities in the COVID-19 Landscape
Table Measures / Proposal against Covid-19
Table Global Varicella Virus (Chickenpox) Vaccine Sales by Manufacturer (2017-2022)
Figure Global Varicella Virus (Chickenpox) Vaccine Sales Market Share by Manufacturer in 2021
Table Global Varicella Virus (Chickenpox) Vaccine Revenue by Manufacturer (2017-2022)
Figure Global Varicella Virus (Chickenpox) Vaccine Revenue Market Share by Manufacturer in 2021
Table Global Varicella Virus (Chickenpox) Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Figure Top 5 Varicella Virus (Chickenpox) Vaccine Manufacturer (Revenue) Market Share in 2021
Figure Top 10 Varicella Virus (Chickenpox) Vaccine Manufacturer (Revenue) Market Share in 2021
Table Date of Key Manufacturers Enter into Varicella Virus (Chickenpox) Vaccine Market
Table Key Manufacturers Varicella Virus (Chickenpox) Vaccine Product Type
Table Mergers & Acquisitions Planning
Table GSK Company Profile
Table Varicella Virus (Chickenpox) Vaccine Product Introduction, Application and Specification of GSK
Table Varicella Virus (Chickenpox) Vaccine Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company One 2017-2022
Table Company One Main Business
Table Company One Recent Development
Table Merck & Co. Company Profile
Table Varicella Virus (Chickenpox) Vaccine Product Introduction, Application and Specification of Merck & Co.
Table Varicella Virus (Chickenpox) Vaccine Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Merck & Co. Recent Development
Table Sanofi Pasteur Company Profile
Table Varicella Virus (Chickenpox) Vaccine Product Introduction, Application and Specification of Sanofi Pasteur
Table Varicella Virus (Chickenpox) Vaccine Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Sanofi Pasteur Main Business
Table Sanofi Pasteur Recent Development
Table Green Cross Company Profile
Table Varicella Virus (Chickenpox) Vaccine Product Introduction, Application and Specification of Green Cross
Table Varicella Virus (Chickenpox) Vaccine Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Green Cross Main Business
Table Green Cross Recent Development
Table Green Cross Main Business
Table Green Cross Recent Development
Table Shanghai Institute Company Profile
Table Varicella Virus (Chickenpox) Vaccine Product Introduction, Application and Specification of Shanghai Institute
Table Varicella Virus (Chickenpox) Vaccine Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Shanghai Institute Main Business
Table Shanghai Institute Recent Development
Table BCHT Company Profile
Table Varicella Virus (Chickenpox) Vaccine Product Introduction, Application and Specification of BCHT
Table Varicella Virus (Chickenpox) Vaccine Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table BCHT Main Business
Table BCHT Recent Development
Table Changsheng Company Profile
Table Varicella Virus (Chickenpox) Vaccine Product Introduction, Application and Specification of Changsheng
Table Varicella Virus (Chickenpox) Vaccine Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Changsheng Main Business
Table Changsheng Recent Development
Table Keygen Company Profile
Table Varicella Virus (Chickenpox) Vaccine Product Introduction, Application and Specification of Keygen
Table Varicella Virus (Chickenpox) Vaccine Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Keygen Main Business
Table Keygen Recent Development
Table Biken Company Profile
Table Varicella Virus (Chickenpox) Vaccine Product Introduction, Application and Specification of Biken
Table Varicella Virus (Chickenpox) Vaccine Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Biken Main Business
Table Biken Recent Development
Figure Global Varicella Virus (Chickenpox) Vaccine Sales and Growth Rate (2017-2022)
Figure Global Varicella Virus (Chickenpox) Vaccine Revenue and Growth Rate (2017-2022)
Table Global Varicella Virus (Chickenpox) Vaccine Sales by Regions (2017-2022)
Figure Global Varicella Virus (Chickenpox) Vaccine Sales Market Share by Regions in 2021
Table Global Varicella Virus (Chickenpox) Vaccine Revenue by Regions (2017-2022)
Figure Global Varicella Virus (Chickenpox) Vaccine Revenue Market Share by Regions in 2021
Figure North America Varicella Virus (Chickenpox) Vaccine Sales and Growth Rate (2017-2022)
Figure Europe Varicella Virus (Chickenpox) Vaccine Sales and Growth Rate (2017-2022)
Figure China Varicella Virus (Chickenpox) Vaccine Sales and Growth Rate (2017-2022)
Figure Japan Varicella Virus (Chickenpox) Vaccine Sales and Growth Rate (2017-2022)
Figure Southeast Asia Varicella Virus (Chickenpox) Vaccine Sales and Growth Rate (2017-2022)
Figure Other Regions Varicella Virus (Chickenpox) Vaccine Sales and Growth Rate (2017-2022)
Table Global Varicella Virus (Chickenpox) Vaccine Sales by Big Type (2017-2022)
Table Global Varicella Virus (Chickenpox) Vaccine Sales Market Share by Big Type (2017-2022)
Figure Global Varicella Virus (Chickenpox) Vaccine Sales Market Share by Big Type in 2019
Table Global Varicella Virus (Chickenpox) Vaccine Revenue by Big Type (2017-2022)
Table Global Varicella Virus (Chickenpox) Vaccine Revenue Market Share by Big Type (2017-2022)
Table Global Varicella Virus (Chickenpox) Vaccine Revenue Market Share by Big Type in 2019
Figure Global Monovalent Vaccine Sales Growth Rate (2017-2022)
Figure Global Monovalent Vaccine Price (2017-2022)
Figure Global Combination Vaccine Sales Growth Rate (2017-2022)
Table Global Varicella Virus (Chickenpox) Vaccine Sales by Big Application (2017-2022)
Table Global Varicella Virus (Chickenpox) Vaccine Sales Market Share by Big Application (2017-2022)
Figure Global Varicella Virus (Chickenpox) Vaccine Sales Market Share by Big Application in 2019
Figure Global Children Sales Growth Rate (2017-2022)
Figure Global Teenagers Sales Growth Rate (2017-2022)
Figure Global Adults Sales Growth Rate (2017-2022)
Figure Global Varicella Virus (Chickenpox) Vaccine Sales and Growth Rate (2022-2027)
Figure Global Varicella Virus (Chickenpox) Vaccine Revenue and Growth Rate (2022-2027)
Table Global Varicella Virus (Chickenpox) Vaccine Sales Forecast by Regions (2022-2027)
Table Global Varicella Virus (Chickenpox) Vaccine Market Share Forecast by Regions (2022-2027)
Figure North America Sales Varicella Virus (Chickenpox) Vaccine Market Forecast (2022-2027)
Figure Europe Sales Varicella Virus (Chickenpox) Vaccine Market Forecast (2022-2027)
Figure China Sales Varicella Virus (Chickenpox) Vaccine Market Forecast (2022-2027)
Figure Japan Sales Varicella Virus (Chickenpox) Vaccine Market Forecast (2022-2027)
Figure Southeast Asia Sales Varicella Virus (Chickenpox) Vaccine Market Forecast (2022-2027)
Figure Other Regions Sales Varicella Virus (Chickenpox) Vaccine Market Forecast (2022-2027)
Table Global Varicella Virus (Chickenpox) Vaccine Sales Forecast by Type (2022-2027)
Table Global Varicella Virus (Chickenpox) Vaccine Market Share Forecast by Type (2022-2027)
Table Global Varicella Virus (Chickenpox) Vaccine Sales Forecast by Application (2022-2027)
Table Global Varicella Virus (Chickenpox) Vaccine Market Share Forecast by Application (2022-2027)
Table Market Opportunities in Next Few Years
Table Market Risks Analysis
Table Market Drivers
Figure Porter's Five Forces Analysis
Table Macro Analysis of Upstream Markets
Table Key Players in Upstream Markets
Table Key Players of Upstream Markets
Table Key Raw Materials
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Varicella Virus (Chickenpox) Vaccine
Table Macro Analysis of Down Markets
Table Key Players in Down Markets
Table Key Players of Downstream Markets
Figure Sales Channel
Figure North America Varicella Virus (Chickenpox) Vaccine Sales (K Units) Growth Rate Forecast (2021-2025)
Figure North America Varicella Virus (Chickenpox) Vaccine Revenue (Million US$) Growth Rate Forecast (2021-2025)
Figure Europe Varicella Virus (Chickenpox) Vaccine Sales (K Units) Growth Rate Forecast (2021-2025)
Figure Europe Varicella Virus (Chickenpox) Vaccine Revenue (Million US$) Growth Rate Forecast (2021-2025)
Figure Japan Varicella Virus (Chickenpox) Vaccine Production (K Units) Growth Rate Forecast (2021-2025)
Figure Japan Varicella Virus (Chickenpox) Vaccine Revenue (Million US$) Growth Rate Forecast (2021-2025)
Figure China Varicella Virus (Chickenpox) Vaccine Production (K Units) Growth Rate Forecast (2021-2025)
Figure China Varicella Virus (Chickenpox) Vaccine Revenue (Million US$) Growth Rate Forecast (2021-2025)
Figure Methodology/Research Approach
Figure Market Size Estimation
Figure Author List
GSK
Merck & Co.
Sanofi Pasteur
Green Cross
Shanghai Institute
BCHT
Changsheng
Global Freckle-removing Medical and Beau..
The global market for Freckle-removing Medical and Beauty Eq..
+16467917070US (Toll Free)